Yael Hayon
Chief Tech/Sci/R&D Officer bei PROTALIX BIOTHERAPEUTICS, INC.
Vermögen: 44 245 $ am 31.03.2024
Profil
Yael Hayon is currently the Vice President of Research & Development at Protalix Biotherapeutics, Inc. She previously worked as the Manager of Research & Development at Stem Cell Medicine Ltd.
from 2014 to 2016, and as the Head of Research & Development at LogicBio Therapeutics, Inc. from 2016 to 2020.
She also served as the Vice President of Clinical Affairs at Syqe Medical Ltd.
Additionally, Dr. Hayon holds a graduate and doctorate degree from The Hebrew University of Jerusalem.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.08.2023 | 35 115 ( 0,05% ) | 44 245 $ | 31.03.2024 |
Aktive Positionen von Yael Hayon
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 05.07.2020 |
Ehemalige bekannte Positionen von Yael Hayon
| Unternehmen | Position | Ende |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2020 |
Stem Cell Medicine Ltd.
 Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Stemcell Medicine Ltd. develops and commercializes cellular therapies. It develops products from a number of tissue sources, such as adipose tissue stem cells for ischemic indications and from T cells for solid tumor-directed immunotherapies. The company was founded by Ehud Marom in 2010 and is headquartered in Jerusalem, IL. | Chief Tech/Sci/R&D Officer | 01.01.2016 |
Syqe Medical Ltd.
 Syqe Medical Ltd. Medical SpecialtiesHealth Technology Syqe Medical Ltd. develops 3D-printed hand-held cannabis inhalers. It offers Syqe Inhaler Exo, a hospital version metered-dose cannabis inhaler for professional healthcare use, including pain clinics, cancer centers and intensive care units. The company was founded by Perry Davidson in 2011 and is headquartered in Tel Aviv, Israel. | Corporate Officer/Principal | - |
Ausbildung von Yael Hayon
| The Hebrew University of Jerusalem | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Stem Cell Medicine Ltd.
Stem Cell Medicine Ltd. Pharmaceuticals: OtherHealth Technology Stemcell Medicine Ltd. develops and commercializes cellular therapies. It develops products from a number of tissue sources, such as adipose tissue stem cells for ischemic indications and from T cells for solid tumor-directed immunotherapies. The company was founded by Ehud Marom in 2010 and is headquartered in Jerusalem, IL. | Health Technology |
Syqe Medical Ltd.
Syqe Medical Ltd. Medical SpecialtiesHealth Technology Syqe Medical Ltd. develops 3D-printed hand-held cannabis inhalers. It offers Syqe Inhaler Exo, a hospital version metered-dose cannabis inhaler for professional healthcare use, including pain clinics, cancer centers and intensive care units. The company was founded by Perry Davidson in 2011 and is headquartered in Tel Aviv, Israel. | Health Technology |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
